Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 12:01 p.m.

    📋 NRX PHARMACEUTICALS, INC. (NRXP) - Clinical Trial Update

    Filing Date: 2026-08-17

    Accepted: 2026-08-17 08:00:30

    Event Type: Clinical Trial Update

    Event Details:

    NRX PHARMACEUTICALS, INC. (NRXP) Announces Clinical Trial Update NRX PHARMACEUTICALS, INC. (NRXP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: stock, operations
    • Diseases/Conditions: SPARC-TMS, gross proceeds of $22
    • Clinical Stage: Phase 2
    • Collaboration: TMS
      • anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise. For further information: Brian Korb Managing Partner, astr partners(917) 653-5122

    🔬 Clinical Development Pipeline (NRX PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    SF1126 DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    KX2-391 DRUG Phase PHASE1 Acute Myelogenous Leukemia ClinicalTrials.gov
    Oraxol DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Placebo DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    VNRX-5133 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Metronidazole DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    VNRX-5022 DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    VNRX-5133 and VNRX-5022 DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    VNRX-5133 + cefepime DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Nivolumab DRUG Phase PHASE1 Advanced Hepatocellular Carcinoma ClinicalTrials.gov
    Ceftibuten DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    VNRX-7145 DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    ledaborbactam etzadroxil DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    Meropenem DRUG Phase PHASE3 Ventilator-associated Pneumonia ClinicalTrials.gov
    Cefepime-taniborbactam DRUG Phase PHASE3 Ventilator-associated Pneumonia ClinicalTrials.gov
    VNRX-5024 (ceftibuten) DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Placebo for VNRX-5024 DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    VNRX-5024 DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Placebo for VNRX-9945 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    VNRX-9945 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Esomeprazole DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Ceftibuten-ledaborbactam etzadroxil DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NRX PHARMACEUTICALS, INC.
    • Ticker Symbol: NRXP

Search

News categories